Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study.
2013-01-01 Morabito, A; Gebbia, V; Di Maio, M; Cinieri, S; Viganò, Mg; Bianco, R; Barbera, S; Cavanna, L; De Marinis, F; Montesarchio, V; Costanzo, R; Sandomenico, C; Montanino, A; Mancuso, G; Russo, P; Nacci, A; Giordano, P; Daniele, G; Piccirillo, Mc; Rocco, G; Gridelli, C; Gallo, C; Perrone, F.
A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer.
2013-01-01 de Marinis, F; Atmaca, A; Tiseo, M; Giuffreda, L; Rossi, A; Gebbia, V; D'Antonio, C; Dal Zotto, L; Al-Batran, Se; Marsoni, S; Wolf, M.
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
2014-01-01 Butts, C; Socinski, Ma; Mitchell, Pl; Thatcher, N; Havel, L; Krzakowski, M; Nawrocki, S; Ciuleanu, Te; Bosquée, L; Trigo, Jm; Spira, A; Tremblay, L; Nyman, J; Ramlau, R; Wickart-Johansson, G; Ellis, P; Gladkov, O; Pereira, Jr; Eberhardt, We; Helwig, C; Schröder, A; Shepherd FA Shepherd, F; Butts, C; Thatcher, N; Socinski, M; Mitchell, P; Talbot, D; Gillen, D; Whang-Peng, J; Thirwell, M; Seeber, S; Braun, D; Schröder, A; Falk, M; Günther, B; Marschner, Jp; Helwig, C; Loos, A; Tyroller, K; Schüler, A; Ferrande, L; Gaumond, B; Olchowka, K; Koh, P; Mackiewicz, M; Sylvester, E; Wallis, N; Joerg, I; Schick, R; Munn, J; Best, M; Campbell, A; Laszczewska, V; Parvez, T; Ferro, A; Tremblay, L; Sadjadian, P; Smit, E; Park, K; Kotz, K; Borghaei, H; Stehle, I; Ismael, C; Alam, Z; Engel-Riedel, W; Stigt, J; García Girón, C; Kumar, K; Oton, A; Jäger, E; Pasccon, Gv; von Ksienski, D; Pawel, J; van den Borne, B; Trigo, Jm; Lester, E; Nader, D; Kortsik, C; Martin, C; Murray, N; Serke, M; van den Heuvel, M; Vazquez, S; March, R; Li, Z; Wolf, M; Pallotta, M; Macneil, M; Georgoulias, V; van Ojik, H; López Vivanco, G; Masri, M; Espinoza, A; Rüttinger, D; Perazzo, F; Hirsh, V; Kosmidis, P; Krouwels, F; Paredes, A; Shinn, L Jr; Limentani, S; Eschbach, C; Ponce, W; Findlay, B; Pectasides, D; Chmielowska, E; Viñolas, N; Mirtsching, B; Pincus, S; Gahn, B; Fein, L; Burkes, R; Syrigos, K; Jagiello-Gruszfeld, A; Massuti, B; Okazaki, I; Young, D; Kollmeier, J; Zarbá, J; Maccormick, R; Fountzilas, G; Kozielski, J; Gonzalez-Larriba, Jl; Saleh, M; Nugent, F 3rd; Gütz, S; Bella, S; Wang, J; Samantas, E; Krzakowski, M; Barragán, Pl; Curran, C; Chaudhry, A; Wilke, H; Bagnes, C; Sun, Y; Lee, V; Lesniewski-Kmak, K; Alonso, G; Gabrail, N; Ndum, P; Reck, M; Mitchell, P; Koubková, L; Mok, T; Ramlau, R; Bosch, J; Abbott, K; Beall, C; Shepherd, F; Millward, M; Reiterer, P; Albert, I; Rysz-Postawa, B; Moreno, Ma; Bellam, S; Nieva, J; Maksymiuk, A; Boyer, M; Roubec, J; Losonczy, G; Labij, V; de Castro, J; Charu, V; Modi, S; Butts, C; Mccaffrey, E; Salajka, F; Szima, B; Rusinowska, Z; Wichardt-Johansson, G; Erlich, R; Dudek, A; Ellis, P; Pavlakis, N; Havel, L; Zsiray, M; Szczesna, A; Ewers, Sv; Page, R; Ghazal, H; Lee, C; Crombie, C; Zemanová, M; Szabó, P; Freier, B; Henriksson, R; Rao, H; Gitlitz, B; Desjardins, P; Kirsten, F; Hansen, O; Bittner, N; Kus, J; Nyman, J; Sanborn, R; Harrer, G; Vergidis, D; Pirker, R; Ryberg, M; Bittner, N; Sawrycki, P; Nilsson, K; Bruno, D; Mehdi, A; Cohen, V; Kolb, R; Louridi, Jb; Chacko, R; Chojnacka, M; Bergström, S; Shah, S; Jones, C; Bebb, G; Mohn-Staudner, A; Robinet, G; Raja, R; Nawrocki, S; Zippelius, A; Shirinian, M; Gotovkin, E; Soulières, D; Greil, R; Zalcman, G; Julka, Pk; Fijuth, J; Pless, M; Abdel Karim, I; Soo, R; Thropay, J; Hilbe, W; Choma, D; Digumarti, R; Barata, Fj; Mach, N; Neerukonda, L; Kasan, P; Akunyili, I; Kropfmüller, R; Verkindre, C; Advani, S; Teixeira, E; Yang, Ch; Bonomi, P; Packan, T; Argiris, A; Samonigg, H; Dumont, P; Vamsy, M; Almodovar, Mt; Liu, Mc; Rakkar, A; Berzinec, P; Edelman, M; Vansteenkiste, J; Tourani, Jm; O'Byrne, K; Araújo, A; Hsia, Tc; Rao, R; Kang, Jh; Natale, R; Lambrechts, M; Gervais, R; Cyjon, A; Dediu, M; Chang, Gc; Dowlati, A; Kim, Sw; Ottensmeier, C; Humblet, Y; Schott, R; Dudnik, J; Anghel, R; Chen, Ym; Weiss, J; Lee, Js; Collinson, M; Duplaquet, F; Spaeth, D; Gottfried, M; Ciuleanu, Td; Tsao, Ch; Spira, A; Kim, Jh; Thomas, G; Louis, R; Barlesi, F; Merimsky, O; Volovat, C; Kuo, Hp; Langer, C; Heo, Ds; O'Brien, M; Clinckart, F; Fabre-Guillevin, E; Peylan-Ramu, N; Ganea Motan, De; Huang, Ms; Vrindavanam, N; Gebbia, V; Macgregor, C; Verhoeven, D; Pibarot, M; Sulkes, A; Patran, M; Su, Wc; Bhanja, U; Ciardiello, F; Tjulandin, S; de Azevedo, S; Westeel, V; Wollner, M; Sirbu, D; Lin, Mc; Hoffman, S; Grossi, F; Popov, V; Barrios, Ch; Mornex, F; Onn, A; Cheporov, S; Price, A; Bednar, M; Aglietta, M; Goldberg, V; Delgado, G; Thomas, M; Platania, M; Gladkov, O; Snee, M; Bhaskar, B; Contu, A; Medvedev, V; Franke, Fa; Waller, C; Siena, C; Mikhaylov, S; Dorey, N; Caputto, S; Gridelli, C; Khasanov, R; Malzyner, A; Eberhardt, W; Amadori, D; Lubennikov, V; Marshall, E; Chen, Lc; Guevara Torres, A; Santoro, A; Nugué, P; Schneller, F; De Marinis, F; Akhmadullina, L; Ezhil, M; West, H; Trigueros Velázquez, M; Scagliotti, G; Pizão, ; Griesinger, F; Longo, L; Byakhov, M; Hicks, J; Berg, A; Ramírez Márquez, M; Tiseo, M; Segalla, ; Hildebrandt, G; Martoni, A; Moiseyenko, V; Taylor, P; Hays, J; Arrieta Rodriguez, Og; Caffo, O; Mathias, Cm; Huber, R; Witt, C; Murad, A; Höffken, G; Gorini, C; Zukin, M; Iacobelli, S; Pereira, J; Schreiber, J; Wehler, T.
Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study
2013-01-01 Zerbi, A; Capitanio, V; Boninsegna, L; Delle Fave, G; Pasquali, C; Rindi, G; Campana, D; Falconi, M; AISP-Network Study Group., Di Carlo V; Pederzoli, P; Delle Fave, G; Pedrazzoli, S; Tomassetti, P; Garcea, D; Uomo, G; Colangelo, E; Mosca, F; Fronda, Gr; Bresadola, F; Cantore, M; Leone, Be; Farinati, F; Toma, S; Luppi, G; Bene, A; Bajetta, E; Ruffini, L; Gebbia, V; Liguori, L; De Toma, G; Dogliotti, L; Massidda, B.
Lung Cancer. 2013 Sep;81(3):428-34. doi: 10.1016/j.lungcan.2013.05.010. Epub 2013 Jun 20. Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer.
2013-01-01 Schmid-Bindert, G; Gebbia, V; Mayer, F; Arriola, E; Márquez-Medina, D; Syrigos, K; Biesma, B; Leschinger, Mi; Frimodt-Moller, B; Ripoche, V; Myrand, Sp; Nguyen, Ts; Hozak, Rr; Zimmermann, A; Visseren-Grul, C; Schuette, W.
Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit
2013-01-01 Mercadante, S; Guccione, C; Di Fatta, S; Alaimo, V; Prestia, G; Bellingardo, R; Gebbia, Vittorio; Giarratano, Antonino; Casuccio, Alessandra
New opioids.
2014-01-01 Mercadante, S; Porzio, G; Gebbia, V
Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy:a multicenter phase III study
2014-01-01 Lorusso, V; Giotta, F; Bordonaro, R; Maiello, E; Del Prete, S; Gebbia, V; Filippelli, G; Pisconti, S; Cinieri, S; Romito, S; Riccardi, F; Forcignanò, R; Ciccarese, M; Petrucelli, L; Saracino, V; Lupo, Li; Gambino, A; Leo, S; Colucci, G; Gruppo Oncologico Dell'Italia, Meridionale.
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
2015-01-01 Di Maio, M; Gallo, C; Leighl, Nb; Piccirillo, Mc; Daniele, G; Nuzzo, F; Gridelli, C; Gebbia, V; Ciardiello, F; De Placido, S; Ceribelli, A; Favaretto, Ag; de Matteis, A; Feld, R; Butts, C; Bryce, J; Signoriello, S; Morabito, A; Rocco, G; Perrone, F.
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study.
2015-01-01 Santoro, A; Gebbia, V; Pressiani, T; Testa, A; Personeni, N; Bajardi, Ea; Foa, P; Buonadonna, A; Bencardino, K; Barone, C; Ferrari, D; Zaniboni, A; Tronconi, Mc; Cartenì, G; Milella, M; Comandone, A; Ferrari, S; Rimassa, L.
Una nuova iscrizione punica su un cippo funerario da Mozia
2023-01-01 DE SIMONE, Rossana
Psychometric validation of the French Multidimensional Chronic Asthenia Scale (MCAS) in a sample of 621 patients with chronic fatigue
2023-01-01 Banovic, I.; Scrima, F.; Fornasieri, I.; Beaugerie, L.; Coquart, J.; Fourgon, C.; Iodice, P.; Nion-Larmurier, I.; Savoye, G.; Sorin, A. -L.; Tourny, C.; Augustinova, M.
Organizational Culture, Justice, Dehumanization and Affective Commitment in French Employees: A Serial Mediation Model
2023-01-01 Hamel, J. -F.; Scrima, F.; Massot, L.; Montalan, B.
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial
2015-01-01 Machiels, Jean-Pascal H; Haddad, Robert I; Fayette, Jérôme; Licitra, Lisa F; Tahara, Makoto; Vermorken, Jan B; Clement, Paul M; Gauler, Thomas; Cupissol, Didier; Grau, Juan José; Guigay, Joël; Caponigro, Francesco; de Castro, Gilberto; de Souza Viana, Luciano; Keilholz, Ulrich; del Campo, Joseph M; Cong, Xiuyu Julie; Ehrnrooth, Eva; Cohen, ; Ezra, E W; Gebbia, V
Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE)
2011-01-01 Galetta, D; Pisconti, S; Cinieri, S; Pappagallo, Gl; Gebbia, V; Borsellino, N; Maiello, E; Rinaldi, A; Montrone, M; Rizzo, P; Marzano, N; Sasso, N; Febbraro, A; Colucci, G.
Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma
2016-01-01 Apice, G; Pizzolorusso, A; Di Maio, M; Grignani, G; Gebbia, V; Buonadonna, A; De Chiara, A; Fazioli, F; De Palma, G; Galizia, D; Arcara, C; Mozzillo, N; Perrone, F.
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin plus etoposide in extensive small-cell lung cancer (SCLC) patients The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial
2017-01-01 Morabito, A; Daniele, G; Costanzo, R; Favaretto, Ag; Filipazzi, V; Rossi, A; Gebbia, V; Castiglione, F; Cavanna, L; Maiello, E; Sandomenico, C; Bonanno, L; Piazza, E; Maione, P; Piccirillo, Mc; Di Maio, M; Rocco, G; Gallo, C; Perrone, F; Gridelli, C
Erratum to “Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy”
2018-01-01 Genova, Pietro; Sorce, Maria; Cabibi, Daniela; Genova, Gaspare; Gebbia, Vittorio; Galanti, Daniele; Ancona, Chiara; Valerio, Mara Rosaria
Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy
2017-01-01 Genova, Pietro; Sorce, Maria; Cabibi, Daniela; Genova, Gaspare; Gebbia, Vittorio; Galanti, Daniela; Ancona, Chiara; Valerio, Maria Rosaria
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study
2018-01-01 Cazzaniga, M.; Verusio, C.; Ciccarese, M.; Fumagalli, A.; Sartori, D.; Valerio, Mr.; Airoldi, M.; Moretti, G.; Ficorella, C.; Arcangeli, V.; Diodati, L.; Zambelli, A.; Febbraro, A.; Generali, D.; Pistelli, M.; Garrone, O.; Musolino, A.; Vici, P.; Maur, M.; Mentuccia, L.; La Verde, N.; Bianchi, G.; Artale, S.; Blasi, L.; Piezzo, M.; Atzori, F.; Turletti, A.; Benedetto, C.; Cursano, M. C.; Fabi, A.; Gebbia, V.; Schirone, A.; Palumbo, R.; Ferzi, A.; Frassoldati, A.; Scavelli, C.; Clivio, L.; Torri, V.; On behalf of The EVA Study, Group
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study. | 1-gen-2013 | Morabito, A; Gebbia, V; Di Maio, M; Cinieri, S; Viganò, Mg; Bianco, R; Barbera, S; Cavanna, L; De Marinis, F; Montesarchio, V; Costanzo, R; Sandomenico, C; Montanino, A; Mancuso, G; Russo, P; Nacci, A; Giordano, P; Daniele, G; Piccirillo, Mc; Rocco, G; Gridelli, C; Gallo, C; Perrone, F. | |
| A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer. | 1-gen-2013 | de Marinis, F; Atmaca, A; Tiseo, M; Giuffreda, L; Rossi, A; Gebbia, V; D'Antonio, C; Dal Zotto, L; Al-Batran, Se; Marsoni, S; Wolf, M. | |
| Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial. | 1-gen-2014 | Butts, C; Socinski, Ma; Mitchell, Pl; Thatcher, N; Havel, L; Krzakowski, M; Nawrocki, S; Ciuleanu, Te; Bosquée, L; Trigo, Jm; Spira, A; Tremblay, L; Nyman, J; Ramlau, R; Wickart-Johansson, G; Ellis, P; Gladkov, O; Pereira, Jr; Eberhardt, We; Helwig, C; Schröder, A; Shepherd FA Shepherd, F; Butts, C; Thatcher, N; Socinski, M; Mitchell, P; Talbot, D; Gillen, D; Whang-Peng, J; Thirwell, M; Seeber, S; Braun, D; Schröder, A; Falk, M; Günther, B; Marschner, Jp; Helwig, C; Loos, A; Tyroller, K; Schüler, A; Ferrande, L; Gaumond, B; Olchowka, K; Koh, P; Mackiewicz, M; Sylvester, E; Wallis, N; Joerg, I; Schick, R; Munn, J; Best, M; Campbell, A; Laszczewska, V; Parvez, T; Ferro, A; Tremblay, L; Sadjadian, P; Smit, E; Park, K; Kotz, K; Borghaei, H; Stehle, I; Ismael, C; Alam, Z; Engel-Riedel, W; Stigt, J; García Girón, C; Kumar, K; Oton, A; Jäger, E; Pasccon, Gv; von Ksienski, D; Pawel, J; van den Borne, B; Trigo, Jm; Lester, E; Nader, D; Kortsik, C; Martin, C; Murray, N; Serke, M; van den Heuvel, M; Vazquez, S; March, R; Li, Z; Wolf, M; Pallotta, M; Macneil, M; Georgoulias, V; van Ojik, H; López Vivanco, G; Masri, M; Espinoza, A; Rüttinger, D; Perazzo, F; Hirsh, V; Kosmidis, P; Krouwels, F; Paredes, A; Shinn, L Jr; Limentani, S; Eschbach, C; Ponce, W; Findlay, B; Pectasides, D; Chmielowska, E; Viñolas, N; Mirtsching, B; Pincus, S; Gahn, B; Fein, L; Burkes, R; Syrigos, K; Jagiello-Gruszfeld, A; Massuti, B; Okazaki, I; Young, D; Kollmeier, J; Zarbá, J; Maccormick, R; Fountzilas, G; Kozielski, J; Gonzalez-Larriba, Jl; Saleh, M; Nugent, F 3rd; Gütz, S; Bella, S; Wang, J; Samantas, E; Krzakowski, M; Barragán, Pl; Curran, C; Chaudhry, A; Wilke, H; Bagnes, C; Sun, Y; Lee, V; Lesniewski-Kmak, K; Alonso, G; Gabrail, N; Ndum, P; Reck, M; Mitchell, P; Koubková, L; Mok, T; Ramlau, R; Bosch, J; Abbott, K; Beall, C; Shepherd, F; Millward, M; Reiterer, P; Albert, I; Rysz-Postawa, B; Moreno, Ma; Bellam, S; Nieva, J; Maksymiuk, A; Boyer, M; Roubec, J; Losonczy, G; Labij, V; de Castro, J; Charu, V; Modi, S; Butts, C; Mccaffrey, E; Salajka, F; Szima, B; Rusinowska, Z; Wichardt-Johansson, G; Erlich, R; Dudek, A; Ellis, P; Pavlakis, N; Havel, L; Zsiray, M; Szczesna, A; Ewers, Sv; Page, R; Ghazal, H; Lee, C; Crombie, C; Zemanová, M; Szabó, P; Freier, B; Henriksson, R; Rao, H; Gitlitz, B; Desjardins, P; Kirsten, F; Hansen, O; Bittner, N; Kus, J; Nyman, J; Sanborn, R; Harrer, G; Vergidis, D; Pirker, R; Ryberg, M; Bittner, N; Sawrycki, P; Nilsson, K; Bruno, D; Mehdi, A; Cohen, V; Kolb, R; Louridi, Jb; Chacko, R; Chojnacka, M; Bergström, S; Shah, S; Jones, C; Bebb, G; Mohn-Staudner, A; Robinet, G; Raja, R; Nawrocki, S; Zippelius, A; Shirinian, M; Gotovkin, E; Soulières, D; Greil, R; Zalcman, G; Julka, Pk; Fijuth, J; Pless, M; Abdel Karim, I; Soo, R; Thropay, J; Hilbe, W; Choma, D; Digumarti, R; Barata, Fj; Mach, N; Neerukonda, L; Kasan, P; Akunyili, I; Kropfmüller, R; Verkindre, C; Advani, S; Teixeira, E; Yang, Ch; Bonomi, P; Packan, T; Argiris, A; Samonigg, H; Dumont, P; Vamsy, M; Almodovar, Mt; Liu, Mc; Rakkar, A; Berzinec, P; Edelman, M; Vansteenkiste, J; Tourani, Jm; O'Byrne, K; Araújo, A; Hsia, Tc; Rao, R; Kang, Jh; Natale, R; Lambrechts, M; Gervais, R; Cyjon, A; Dediu, M; Chang, Gc; Dowlati, A; Kim, Sw; Ottensmeier, C; Humblet, Y; Schott, R; Dudnik, J; Anghel, R; Chen, Ym; Weiss, J; Lee, Js; Collinson, M; Duplaquet, F; Spaeth, D; Gottfried, M; Ciuleanu, Td; Tsao, Ch; Spira, A; Kim, Jh; Thomas, G; Louis, R; Barlesi, F; Merimsky, O; Volovat, C; Kuo, Hp; Langer, C; Heo, Ds; O'Brien, M; Clinckart, F; Fabre-Guillevin, E; Peylan-Ramu, N; Ganea Motan, De; Huang, Ms; Vrindavanam, N; Gebbia, V; Macgregor, C; Verhoeven, D; Pibarot, M; Sulkes, A; Patran, M; Su, Wc; Bhanja, U; Ciardiello, F; Tjulandin, S; de Azevedo, S; Westeel, V; Wollner, M; Sirbu, D; Lin, Mc; Hoffman, S; Grossi, F; Popov, V; Barrios, Ch; Mornex, F; Onn, A; Cheporov, S; Price, A; Bednar, M; Aglietta, M; Goldberg, V; Delgado, G; Thomas, M; Platania, M; Gladkov, O; Snee, M; Bhaskar, B; Contu, A; Medvedev, V; Franke, Fa; Waller, C; Siena, C; Mikhaylov, S; Dorey, N; Caputto, S; Gridelli, C; Khasanov, R; Malzyner, A; Eberhardt, W; Amadori, D; Lubennikov, V; Marshall, E; Chen, Lc; Guevara Torres, A; Santoro, A; Nugué, P; Schneller, F; De Marinis, F; Akhmadullina, L; Ezhil, M; West, H; Trigueros Velázquez, M; Scagliotti, G; Pizão, ; Griesinger, F; Longo, L; Byakhov, M; Hicks, J; Berg, A; Ramírez Márquez, M; Tiseo, M; Segalla, ; Hildebrandt, G; Martoni, A; Moiseyenko, V; Taylor, P; Hays, J; Arrieta Rodriguez, Og; Caffo, O; Mathias, Cm; Huber, R; Witt, C; Murad, A; Höffken, G; Gorini, C; Zukin, M; Iacobelli, S; Pereira, J; Schreiber, J; Wehler, T. | |
| Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study | 1-gen-2013 | Zerbi, A; Capitanio, V; Boninsegna, L; Delle Fave, G; Pasquali, C; Rindi, G; Campana, D; Falconi, M; AISP-Network Study Group., Di Carlo V; Pederzoli, P; Delle Fave, G; Pedrazzoli, S; Tomassetti, P; Garcea, D; Uomo, G; Colangelo, E; Mosca, F; Fronda, Gr; Bresadola, F; Cantore, M; Leone, Be; Farinati, F; Toma, S; Luppi, G; Bene, A; Bajetta, E; Ruffini, L; Gebbia, V; Liguori, L; De Toma, G; Dogliotti, L; Massidda, B. | |
| Lung Cancer. 2013 Sep;81(3):428-34. doi: 10.1016/j.lungcan.2013.05.010. Epub 2013 Jun 20. Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer. | 1-gen-2013 | Schmid-Bindert, G; Gebbia, V; Mayer, F; Arriola, E; Márquez-Medina, D; Syrigos, K; Biesma, B; Leschinger, Mi; Frimodt-Moller, B; Ripoche, V; Myrand, Sp; Nguyen, Ts; Hozak, Rr; Zimmermann, A; Visseren-Grul, C; Schuette, W. | |
| Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit | 1-gen-2013 | Mercadante, S; Guccione, C; Di Fatta, S; Alaimo, V; Prestia, G; Bellingardo, R; Gebbia, Vittorio; Giarratano, Antonino; Casuccio, Alessandra | |
| New opioids. | 1-gen-2014 | Mercadante, S; Porzio, G; Gebbia, V | |
| Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy:a multicenter phase III study | 1-gen-2014 | Lorusso, V; Giotta, F; Bordonaro, R; Maiello, E; Del Prete, S; Gebbia, V; Filippelli, G; Pisconti, S; Cinieri, S; Romito, S; Riccardi, F; Forcignanò, R; Ciccarese, M; Petrucelli, L; Saracino, V; Lupo, Li; Gambino, A; Leo, S; Colucci, G; Gruppo Oncologico Dell'Italia, Meridionale. | |
| Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials | 1-gen-2015 | Di Maio, M; Gallo, C; Leighl, Nb; Piccirillo, Mc; Daniele, G; Nuzzo, F; Gridelli, C; Gebbia, V; Ciardiello, F; De Placido, S; Ceribelli, A; Favaretto, Ag; de Matteis, A; Feld, R; Butts, C; Bryce, J; Signoriello, S; Morabito, A; Rocco, G; Perrone, F. | |
| A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study. | 1-gen-2015 | Santoro, A; Gebbia, V; Pressiani, T; Testa, A; Personeni, N; Bajardi, Ea; Foa, P; Buonadonna, A; Bencardino, K; Barone, C; Ferrari, D; Zaniboni, A; Tronconi, Mc; Cartenì, G; Milella, M; Comandone, A; Ferrari, S; Rimassa, L. | |
| Una nuova iscrizione punica su un cippo funerario da Mozia | 1-gen-2023 | DE SIMONE, Rossana | |
| Psychometric validation of the French Multidimensional Chronic Asthenia Scale (MCAS) in a sample of 621 patients with chronic fatigue | 1-gen-2023 | Banovic, I.; Scrima, F.; Fornasieri, I.; Beaugerie, L.; Coquart, J.; Fourgon, C.; Iodice, P.; Nion-Larmurier, I.; Savoye, G.; Sorin, A. -L.; Tourny, C.; Augustinova, M. | |
| Organizational Culture, Justice, Dehumanization and Affective Commitment in French Employees: A Serial Mediation Model | 1-gen-2023 | Hamel, J. -F.; Scrima, F.; Massot, L.; Montalan, B. | |
| Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial | 1-gen-2015 | Machiels, Jean-Pascal H; Haddad, Robert I; Fayette, Jérôme; Licitra, Lisa F; Tahara, Makoto; Vermorken, Jan B; Clement, Paul M; Gauler, Thomas; Cupissol, Didier; Grau, Juan José; Guigay, Joël; Caponigro, Francesco; de Castro, Gilberto; de Souza Viana, Luciano; Keilholz, Ulrich; del Campo, Joseph M; Cong, Xiuyu Julie; Ehrnrooth, Eva; Cohen, ; Ezra, E W; Gebbia, V | |
| Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE) | 1-gen-2011 | Galetta, D; Pisconti, S; Cinieri, S; Pappagallo, Gl; Gebbia, V; Borsellino, N; Maiello, E; Rinaldi, A; Montrone, M; Rizzo, P; Marzano, N; Sasso, N; Febbraro, A; Colucci, G. | |
| Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma | 1-gen-2016 | Apice, G; Pizzolorusso, A; Di Maio, M; Grignani, G; Gebbia, V; Buonadonna, A; De Chiara, A; Fazioli, F; De Palma, G; Galizia, D; Arcara, C; Mozzillo, N; Perrone, F. | |
| A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin plus etoposide in extensive small-cell lung cancer (SCLC) patients The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial | 1-gen-2017 | Morabito, A; Daniele, G; Costanzo, R; Favaretto, Ag; Filipazzi, V; Rossi, A; Gebbia, V; Castiglione, F; Cavanna, L; Maiello, E; Sandomenico, C; Bonanno, L; Piazza, E; Maione, P; Piccirillo, Mc; Di Maio, M; Rocco, G; Gallo, C; Perrone, F; Gridelli, C | |
| Erratum to “Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy” | 1-gen-2018 | Genova, Pietro; Sorce, Maria; Cabibi, Daniela; Genova, Gaspare; Gebbia, Vittorio; Galanti, Daniele; Ancona, Chiara; Valerio, Mara Rosaria | |
| Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy | 1-gen-2017 | Genova, Pietro; Sorce, Maria; Cabibi, Daniela; Genova, Gaspare; Gebbia, Vittorio; Galanti, Daniela; Ancona, Chiara; Valerio, Maria Rosaria | |
| Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study | 1-gen-2018 | Cazzaniga, M.; Verusio, C.; Ciccarese, M.; Fumagalli, A.; Sartori, D.; Valerio, Mr.; Airoldi, M.; Moretti, G.; Ficorella, C.; Arcangeli, V.; Diodati, L.; Zambelli, A.; Febbraro, A.; Generali, D.; Pistelli, M.; Garrone, O.; Musolino, A.; Vici, P.; Maur, M.; Mentuccia, L.; La Verde, N.; Bianchi, G.; Artale, S.; Blasi, L.; Piezzo, M.; Atzori, F.; Turletti, A.; Benedetto, C.; Cursano, M. C.; Fabi, A.; Gebbia, V.; Schirone, A.; Palumbo, R.; Ferzi, A.; Frassoldati, A.; Scavelli, C.; Clivio, L.; Torri, V.; On behalf of The EVA Study, Group |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista15367
- 4 Contributo in Atti di Convegno ...2
- 2 Contributo in Volume1
Data di pubblicazione
- In corso di stampa17
- 2020 - 20267038
- 2010 - 20195807
- 2000 - 20091967
- 1990 - 1999480
- 1980 - 198960
- 1979 - 19791
Editore
- Trans Tech Publications1
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...225
- JOURNAL OF CLINICAL MEDICINE153
- CANCERS122
- INTERNATIONAL JOURNAL OF ENVIRONM...110
- LNS. ACTIVITY REPORT85
- PHD KORE REVIEW78
- DIAGNOSTICS77
- RIVISTA DELLA COOPERAZIONE GIURID...76
- SCIENTIFIC REPORTS73
- SUSTAINABILITY72
Serie
- ADVANCED MATERIALS RESEARCH1
- WORKING PAPERS RES1
Keyword
- COVID-19257
- Humans250
- Female133
- Male127
- SARS-CoV-2108
- inflammation103
- oxidative stress85
- Italy78
- Adult69
- Middle Aged67
Lingua
- eng10819
- ita2587
- fre66
- spa64
- lat12
- ger11
- por6
- ara3
- cat3
- enm2
Accesso al fulltext
- no fulltext15370